MAPT and Alzheimer disease: However, given that EADAM-enriched genes are expressed in much higher levels in our Tau4RΔK-AP microglia, this strongly supports the view that both Aβ and tau pathologies are required to induce disease stage-specific microglia subtypes in AD.